Somatostatinoma
| Somatostatinoma | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Endocrinology, Oncology |
| Symptoms | Diabetes mellitus, gallstones, steatorrhea, weight loss |
| Complications | Metastasis, malabsorption |
| Onset | |
| Duration | |
| Types | |
| Causes | Neuroendocrine tumor |
| Risks | Multiple endocrine neoplasia type 1, von Hippel-Lindau disease |
| Diagnosis | Blood test, imaging studies, biopsy |
| Differential diagnosis | Insulinoma, gastrinoma, glucagonoma |
| Prevention | |
| Treatment | Surgery, chemotherapy, somatostatin analogs |
| Medication | Octreotide, lanreotide |
| Prognosis | Variable, depends on stage and metastasis |
| Frequency | Rare |
| Deaths | N/A |
Somatostatinoma is a rare type of tumor that originates from the somatostatin-producing neuroendocrine cells. These tumors are most commonly found in the pancreas and duodenum.
Symptoms[edit]
The symptoms of somatostatinoma are often nonspecific and can vary depending on the location of the tumor. Common symptoms include diabetes mellitus, gallstones, steatorrhea, and weight loss.
Diagnosis[edit]
The diagnosis of somatostatinoma is typically made through a combination of medical history, physical examination, and laboratory tests. Imaging studies such as computed tomography (CT) or magnetic resonance imaging (MRI) may also be used to locate the tumor.
Treatment[edit]
The primary treatment for somatostatinoma is surgical removal of the tumor. In some cases, chemotherapy or radiation therapy may also be used.
Prognosis[edit]
The prognosis for individuals with somatostatinoma varies depending on the size and location of the tumor, as well as the individual's overall health.
See also[edit]
References[edit]
| Glandular and epithelial cancer | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Tumours of endocrine glands | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|